Marirose Calderon, MD
Internal Medicine · Riverside
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Southern California Permanente Medical Group · 11,250 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Moreno Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Calderon’s office at (951) 353-2000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A151886 · Current
Licensed to practise in California · since 2017 · expires 2026-11-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 87.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Moreno ValleyMoreno Valley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.182, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Moreno Valley
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.182 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.13) · 53 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.47 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 11.4 · 29 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 888 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 290 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 301 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (0.84 to 6.1) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (0.59 to 4.05) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.73) · 237 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.807 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 28 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 90 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 43 cases | None | Jul 2023 – Jun 2025 |
What patients said (592 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$2,692
Medicare paid this office $2,692 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 67 · Health risk score 2.16. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75%.
The office billed $9,954, Medicare allowed $3,343 and paid $2,692; for 26 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 26 | 67 | 2.16 | $9,954 | $2,692 |
| 2023 | 152 | 485 | 78 | 2.26 | $128,186 | $42,968 |
| 2022 | 209 | 782 | 77 | 2.10 | $113,773 | $70,950 |
| 2021 | 221 | 858 | 75 | 2.46 | $109,610 | $80,339 |
| 2020 | 270 | 984 | 76 | 2.49 | $174,631 | $85,464 |
| 2019 | 356 | 910 | 77 | 2.53 | $416,362 | $76,690 |
| 2018 | 621 | 1,529 | 79 | 2.45 | $1,054,788 | $128,621 |
| 2017 | 142 | 308 | 80 | 2.20 | $211,588 | $25,420 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $23,565 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $8,975 | $72 |
| Hospital discharge day management, more than 30 minutes | 54 | $5,405 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $3,770 | $114 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $43,763 | $81 |
| Critical care, first 30-74 minutes | 18 | $6,787 | $170 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,953 | $138 |
| Hospital discharge day management, more than 30 minutes | 68 | $5,832 | $85 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 34 | $4,683 | $134 |
| Advance care planning, first 30 minutes | 12 | $893 | $64 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $43,811 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $10,023 | $154 |
| Critical care, first 30-74 minutes | 17 | $8,715 | $182 |
| Hospital discharge day management, more than 30 minutes | 74 | $6,359 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $5,546 | $56 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 19 | $2,790 | $139 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,511 | $137 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $30,544 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $17,263 | $59 |
| Critical care, first 30-74 minutes | 28 | $12,773 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $11,750 | $140 |
| Hospital discharge day management, more than 30 minutes | 71 | $6,458 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,860 | $33 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $1,854 | $143 |
| Hospital observation care on day of discharge | 16 | $996 | $62 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 185 | $23,994 | $61 |
| Hospital discharge day management, more than 30 minutes | 168 | $15,504 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,250 | $168 |
| Critical care, first 30-74 minutes | 14 | $7,385 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $6,210 | $86 |
| Hospital observation care on day of discharge | 39 | $2,441 | $63 |
| Initial hospital observation care per day, typically 70 minutes | 16 | $2,394 | $150 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $1,427 | $32 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,417 | $109 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,279 | $116 |
| Follow-up observation care per day, typically 25 minutes | 16 | $992 | $62 |
2018: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 309 | $37,675 | $62 |
| Hospital discharge day management, more than 30 minutes | 258 | $24,903 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 123 | $22,810 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $19,931 | $172 |
| Hospital observation care on day of discharge | 105 | $6,648 | $63 |
| Initial hospital observation care per day, typically 70 minutes | 23 | $3,598 | $156 |
| Initial hospital observation care per day, typically 50 minutes | 26 | $3,036 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,781 | $116 |
| Follow-up observation care per day, typically 25 minutes | 29 | $2,074 | $63 |
| Advance care planning, first 30 minutes | 18 | $1,292 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $777 | $32 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $4,974 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,766 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,734 | $88 |
| Hospital discharge day management, more than 30 minutes | 49 | $4,562 | $91 |
| Hospital observation care on day of discharge | 30 | $1,853 | $62 |
| Follow-up observation care per day, typically 25 minutes | 14 | $859 | $61 |
Medicaid work
$3,930 in 2024
Medicaid paid $3,930 for 54 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 26 | $2,340 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 28 | $1,590 |
| 2024 | 54 | 2 | 14 | $3,930 |
| 2023 | 70 | 2 | 13 | $2,026 |
| 2022 | 409 | 2 | 21 | $17,786 |
| 2021 | 258 | 2 | 21 | $15,244 |
| 2020 | 135 | 1 | 15 | $5,877 |
| 2019 | 14 | 1 | 12 | $1,276 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 57 | $2,026 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $0 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 392 | $16,440 |
| 1ST HOSP IP/OBS HIGH 75 | 17 | $1,346 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 217 | $10,608 |
| 1ST HOSP IP/OBS HIGH 75 | 41 | $4,636 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 135 | $5,877 |
2019
| 1ST HOSP IP/OBS HIGH 75 | 14 | $1,276 |
Drugs they prescribed that Part D paid
$16,273
Pharmacies billed $16,273 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (12 of 384) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
330 generic and fewer than 11 brand-name prescriptions · $16,273 in drug cost · 54 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pradaxa | 14 | $2,646 | $189 |
| Pantoprazole | 40 | $347 | $9 |
| Furosemide | 32 | $342 | $11 |
| Cefpodoxime Proxetil | 12 | $268 | $22 |
| Amlodipine Besylate | 15 | $160 | $11 |
See all 10 drugs
| Pradaxa | 14 | $2,646 | $189 |
| Pantoprazole | 40 | $347 | $9 |
| Furosemide | 32 | $342 | $11 |
| Cefpodoxime Proxetil | 12 | $268 | $22 |
| Amlodipine Besylate | 15 | $160 | $11 |
| Prednisone | 20 | $154 | $8 |
| Metoprolol | 14 | $153 | $11 |
| Hydralazine | 12 | $99 | $8 |
| Atorvastatin | 11 | $98 | $9 |
| Azithromycin | 15 | $88 | $6 |
Year by year
| 2024 | 384 | 142 | 3% (12) | None | $16,273 |
| 2023 | 485 | 107 | 3% (14) | None | $26,557 |
| 2022 | 1,023 | 157 | 2% (21) | 12% | $50,876 |
| 2021 | 422 | 114 | 5% (22) | None | $29,044 |
| 2020 | 281 | 100 | 5% (13) | None | $19,394 |
| 2019 | 178 | 81 | None | 12% | $8,722 |
| 2018 | 252 | 106 | 4% (11) | None | $25,054 |
| 2017 | 518 | 75 | None | 23% | $67,844 |
| 2016 | 443 | 38 | None | None | $38,119 |
| 2015 | 436 | 58 | None | None | $57,785 |
| 2014 | 169 | 25 | None | None | $20,400 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Eliquis | 15 | $8,899 | $593 |
| Memantine | 13 | $800 | $62 |
| Cefpodoxime Proxetil | 17 | $618 | $36 |
| Famotidine | 14 | $563 | $40 |
| Metoprolol | 33 | $490 | $15 |
| Atorvastatin | 20 | $413 | $21 |
| Donepezil | 26 | $295 | $11 |
| Omeprazole | 19 | $236 | $12 |
| Allopurinol | 17 | $212 | $12 |
| Pantoprazole | 18 | $188 | $10 |
| Tamsulosin | 14 | $180 | $13 |
| Finasteride | 17 | $174 | $10 |
| Amlodipine Besylate | 11 | $89 | $8 |
| Prednisone | 13 | $73 | $6 |
2022: 33 drugs
| Eliquis | 12 | $7,584 | $632 |
| Aripiprazole | 11 | $1,687 | $153 |
| Atorvastatin | 63 | $1,286 | $20 |
| Memantine | 15 | $1,185 | $79 |
| Entacapone | 12 | $1,015 | $85 |
| Levetiracetam | 24 | $855 | $36 |
| Carbidopa-Levodopa | 11 | $569 | $52 |
| Donepezil | 43 | $520 | $12 |
| Albuterol Sulfate Hfa | 13 | $505 | $39 |
| Omeprazole | 33 | $474 | $14 |
| Finasteride | 33 | $430 | $13 |
| Hydrocortisone | 12 | $427 | $36 |
| Famotidine | 51 | $402 | $8 |
| Calcium Acetate | 14 | $394 | $28 |
| Metoprolol | 26 | $369 | $14 |
| Tamsulosin | 22 | $346 | $16 |
| Levothyroxine | 24 | $345 | $14 |
| Autoshield Duo Pen Needle | 11 | $334 | $30 |
| Clopidogrel | 29 | $312 | $11 |
| Pantoprazole | 17 | $299 | $18 |
| Allopurinol | 17 | $296 | $17 |
| Lisinopril | 33 | $288 | $9 |
| Amiodarone | 14 | $274 | $20 |
| Furosemide | 46 | $249 | $5 |
| Amlodipine Besylate | 28 | $201 | $7 |
| Carvedilol | 16 | $160 | $10 |
| Sertraline | 15 | $121 | $8 |
| Citalopram Hbr | 17 | $111 | $7 |
| Trazodone | 12 | $104 | $9 |
| Hydrocodone-Acetaminophen | 11 | $85 | $8 |
| Cephalexin | 17 | $79 | $5 |
| Prednisone | 17 | $72 | $4 |
| Simvastatin | 12 | $69 | $6 |
2021: 8 drugs
| Levetiracetam | 11 | $331 | $30 |
| Pantoprazole | 25 | $322 | $13 |
| Atorvastatin | 22 | $321 | $15 |
| Omeprazole | 22 | $266 | $12 |
| Metoprolol | 15 | $251 | $17 |
| Clopidogrel | 18 | $175 | $10 |
| Furosemide | 20 | $82 | $4 |
| Cephalexin | 12 | $40 | $3 |
2020: 7 drugs
| Eliquis | 12 | $6,004 | $500 |
| Pantoprazole | 13 | $332 | $26 |
| Atorvastatin | 17 | $177 | $10 |
| Metoprolol | 16 | $153 | $10 |
| Cephalexin | 21 | $119 | $6 |
| Furosemide | 21 | $73 | $3 |
| Amlodipine Besylate | 12 | $50 | $4 |
2019: 3 drugs
| Loperamide | 12 | $554 | $46 |
| Metoprolol | 12 | $190 | $16 |
| Atorvastatin | 13 | $159 | $12 |
2018: 1 drug
| Prednisone | 17 | $97 | $6 |
2017: 13 drugs
| Symbicort | 11 | $3,217 | $292 |
| Metoprolol | 37 | $516 | $14 |
| Atorvastatin | 34 | $317 | $9 |
| Enalapril Maleate | 11 | $213 | $19 |
| Gabapentin | 19 | $164 | $9 |
| Tamsulosin | 17 | $101 | $6 |
| Pantoprazole | 22 | $95 | $4 |
| Omeprazole | 11 | $85 | $8 |
| Amlodipine Besylate | 27 | $83 | $3 |
| Losartan | 17 | $66 | $4 |
| Clopidogrel | 14 | $63 | $4 |
| Metoprolol | 12 | $43 | $4 |
| Hydrochlorothiazide | 12 | $40 | $3 |
2016: 14 drugs
| Symbicort | 13 | $3,369 | $259 |
| Voltaren | 12 | $1,770 | $147 |
| Metoprolol | 31 | $487 | $16 |
| Enalapril Maleate | 18 | $357 | $20 |
| Atorvastatin | 21 | $193 | $9 |
| Pantoprazole | 22 | $119 | $5 |
| Gabapentin | 17 | $106 | $6 |
| Amlodipine Besylate | 38 | $83 | $2 |
| Omeprazole | 11 | $74 | $7 |
| Losartan | 15 | $67 | $4 |
| Clopidogrel | 12 | $61 | $5 |
| Simvastatin | 17 | $48 | $3 |
| Furosemide | 11 | $22 | $2 |
| Hydrochlorothiazide | 14 | $20 | $1 |
2015: 9 drugs
| Crestor | 11 | $2,594 | $236 |
| Proair Hfa | 13 | $657 | $51 |
| Metoprolol | 12 | $252 | $21 |
| Pantoprazole | 15 | $100 | $7 |
| Gabapentin | 13 | $85 | $7 |
| Amlodipine Besylate | 34 | $73 | $2 |
| Simvastatin | 11 | $69 | $6 |
| Hydrochlorothiazide | 21 | $68 | $3 |
| Omeprazole | 11 | $60 | $5 |
Money from drug and device companies
$41 in 2023
| 2023 | 2 | 2 | None | $41 |
| 2021 | 2 | 7 | None | $256 |
| 2020 | 2 | 2 | None | $34 |
| 2019 | 2 | 4 | None | $155 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| AbbVie | Avycaz | $17 | 1 payment
|
See all 2 published payments
| AbbVie | Meals · 2023-03-24 | Avycaz | $17 |
| Janssen Pharmaceuticals | Meals · 2023-03-17 | Xarelto | $24 |
See earlier years (2021, 2020, 2019)
2021: $256
| NxStage Medical | Nxstage System One | $196 | 4 payments
|
| AbbVie | Teflaro | $60 | 3 payments
|
2020: $34
| AstraZeneca Pharmaceuticals LP | Brilinta | $17 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
2019: $155
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $104 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $51 | 3 payments
|
Professional record
- NPI
- 1063837680
- Licence
- CA A151886, HI MD-20498, MA 271044California A151886: Current · expires 2026-11-30
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Hospitalist (208M00000X)
- Mailing address
- 16027 Brookhurst St Ste I-742, Fountain Valley, CA, 92708
- NPI first listed
- 2014-02-19
- NPI last updated
- 2023-10-27
- NPI record certified
- 2023-08-01
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.